Back HIV/AIDS HIV/AIDS Topics HIV-Related Conditions

CROI 2013: HIV+ People Less Likely to Use Aspirin to Prevent Heart Attacks, and May Benefit Less [VIDEO]

People with HIV were less likely than HIV negative people to use daily aspirin to prevent heart attacks, but among those who did, aspirin did not appear to reduce the risk of myocardial infarction (MI), researchers reported last week at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.

alt

Read more:

CROI 2013: Cancer Incidence After Starting Antiretroviral Therapy [VIDEO]

Rates of AIDS-related cancers start to fall not long after initiation of antiretroviral therapy (ART), but non-AIDS cancers rise with increasing time on therapy, according to study findings presented last week at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.

alt

Read more:

People with HIV Have Higher Rates of Non-AIDS Malignancies, Skin Cancer

The incidence of non-AIDS-defining cancers has increased among people with HIV in the era of effective antiretroviral treatment, including malignancies caused by viruses such as human papillomavirus (HPV), and squamous cell non-melanoma skin cancer, according to 2 recently published studies.alt

Read more:

Coverage of the 2013 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com coverage of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), March 3-6, 2013, in Atlanta.

Conference highlights include HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions and complications, treatment as prevention and PrEP, new treatments for hepatitis C, and HIV/HBV and HIV/HCV coinfection.

Full listing by topic

HIVandHepatitis.com CROI 2013 conference section

3/4/13

alt

HIV Treatment Interruption Associated with Reduced Bone Loss in SMART Trial

People who stopped antiretroviral therapy (ART) in the SMART trial had less bone loss and lower levels of bone metabolism biomarkers than people who remained on continuous treatment, according to a report in the January 8, 2013, advance edition of Journal of Bone Mineral Research.

alt

Read more:

CROI 2013: Retrovirus Conference Starts Sunday in Atlanta

The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) kicks off Sunday, March 3, at the Georgia World Congress Center in Atlanta. HIVandHepatitis.com will be on site next week to bring you breaking news coverage on HIV and hepatitis C.

Look for reports from the HIVandHepatitis.com team and our content partners at NAM/Aidsmap.com starting Monday. Sign up for our email newsletter to get the latest headlines and follow us on Twitter @HIVandHepatitis.alt

Read more:

Higher Dose Flu Vaccine Works Better for People with HIV

HIV positive people who received a quadruple dose of a trivalent seasonal influenza vaccine produced more protective antibodies without a significant increase in side effects, researchers reported in the January 1, 2013, Annals of Internal Medicine.
alt

Read more:

HIV Infection May Raise Risk of Sudden Hearing Loss

Young HIV positive people age 18 to 35 had more than twice the likelihood of sudden sensorineural hearing loss compared with their HIV negative counterparts, according to an analysis of nearly 9000 people with HIV described in the February 21, 2013, advance online edition of JAMA Otolaryngology-Head & Neck Surgery.

alt

Read more:

FDA Approves Diarrhea Drug Crofelemer for People with HIV/AIDS

On December 31, the U.S. Food and Drug Administration (FDA) approved crofelemer (brand name Fulyzaq) for treatment of diarrhea in people with HIV/AIDS on antiretroviral therapy (ART) -- the first approved medication for this indication.

alt

Read more: